QA: Biote Corp in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001819253_2023_Biote_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001819253')"}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'100050 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME 2': 3, '100060 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME': 16}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001819253, Biote Corp

  xvar xval
0 LiabilitiesNoncurrent 114,013,000
1 LiabilitiesCurrent 18,766,000
2 remainder_Liabilities 37,140,000
3 AssetsCurrent 101,178,000
4 AssetsNoncurrent 2,052,000
5 PropertyPlantAndEquipmentNet 1,504,000
6 Goodwill 0
7 remainder_Assets 6,911,000
8 GeneralAndAdministrativeExpense 165,502,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 60,565,000
11 remainder_Revenues 164,957,000
12 remainder_NetIncome 62,434,000
13 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Liabilities 169,919,000
1 Assets 111,645,000
2 Expenses 226,067,000
3 Revenues 164,957,000
4 StockholdersEquity -58,274,000
5 NetIncome 1,324,000
6 ComprehensiveNetIncome 1,323,500
7 BaseVar 367,511,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.558
9 EconomicCapitalRatio 0.790

Edgar->Model Mapping

Feature Distribution